Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
115,000
Employees115,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
115,000
Employees115,000

ABT Key Statistics

Market cap
161.47B
Market cap161.47B
Price-Earnings ratio
26.22
Price-Earnings ratio26.22
Dividend yield
2.59%
Dividend yield2.59%
Average volume
15.91M
Average volume15.91M
High today
$94.97
High today$94.97
Low today
$92.67
Low today$92.67
Open price
$94.46
Open price$94.46
Volume
10.24M
Volume10.24M
52 Week high
$137.49
52 Week high$137.49
52 Week low
$81.97
52 Week low$81.97

Stock Snapshot

With a market cap of 161.47B, Abbott(ABT) trades at $92.75. The stock has a price-to-earnings ratio of 26.22 and currently yields dividends of 2.59%.

On 2026-06-29, Abbott(ABT) stock moved within a range of $92.67 to $94.97. With shares now at $92.75, the stock is trading +0.1% above its intraday low and -2.3% below the session's peak.

Trading volume for Abbott(ABT) stock has reached 10.24M, versus its average volume of 15.91M.

The stock's 52-week range extends from a low of $81.97 to a high of $137.49.

The stock's 52-week range extends from a low of $81.97 to a high of $137.49.

ABT News

Simply Wall St 8h
Coca Cola Stock And 2 Defensive Picks For Steady Dividends

Political tensions around the proposed Save America Act and questions about US institutional strength are back in focus, and that can rattle even seasoned inves...

Coca Cola Stock And 2 Defensive Picks For Steady Dividends
TipRanks 16h
Prosecutors prepped to charge Abbott, officials opted for settlement, WSJ says

For years, the Justice Department investigated Abbott (ABT) Laboratories’ baby formula facility, where potentially deadly bacteria was found and suspected of ca...

Nasdaq 1d
In a Volatile Market, This Dividend Growth Stock Is Worth Every Penny of $1,000

Key Points During times of market turmoil, investors cycle back into defensive, dividend-focused names like Abbott Laboratories. Besides Dividend King status...

In a Volatile Market, This Dividend Growth Stock Is Worth Every Penny of $1,000

Analyst ratings

79%

of 29 ratings
Buy
79.3%
Hold
20.7%
Sell
0%

More ABT News

Simply Wall St 3d
Abbott Expands In Europe With Instinct CGM And Emerging Market Medicines

Abbott Laboratories (NYSE:ABT) is rolling out its Instinct continuous glucose monitoring sensor across Europe as part of MiniMed insulin pump systems. The inte...

Abbott Expands In Europe With Instinct CGM And Emerging Market Medicines
24/7 Wall St. 4d
Buy, Hold, or Sell: Tech Compression Dragged Abbott Labs Under $91, but 1 Massive Diabetes Catalyst Makes It a Screaming Buy

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Abbott Laboratories didn't make the cut. Grab the names FREE today . Despi...

Buy, Hold, or Sell: Tech Compression Dragged Abbott Labs Under $91, but 1 Massive Diabetes Catalyst Makes It a Screaming Buy
Simply Wall St 5d
How An ALZpath Alzheimer’s Test Deal And Dividend Streak At Abbott Has Changed Its Investment Story

In June 2026, Abbott’s board declared a quarterly dividend of US$0.63 per share, marking the company’s 410th consecutive quarterly payout since 1924, payable on...

How An ALZpath Alzheimer’s Test Deal And Dividend Streak At Abbott Has Changed Its Investment Story
24/7 Wall St. 5d
Got $2,500? 1 Unstoppable Dividend Aristocrat With an Ironclad Moat to Buy

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Abbott Laboratories didn't make the cut. Grab the names FREE today . At $9...

Got $2,500? 1 Unstoppable Dividend Aristocrat With an Ironclad Moat to Buy
Nasdaq 6d
How Are Emerging Markets Supporting Abbott's EPD Momentum?

Abbott’s ABT Established Pharmaceuticals Division (“EPD”) is heavily focused on emerging markets. In the first quarter of 2026, the segment posted 9% year-over-...

How Are Emerging Markets Supporting Abbott's EPD Momentum?
Nasdaq 6d
ALZpath Inks Licensing Deal With Abbott To Expand Blood-Based Alzheimer's Disease Testing

(RTTNews) - Wednesday, ALZpath Inc. announced a licensing agreement with Abbott Laboratories (ABT) to incorporate the company's proprietary phosphorylated Tau 2...

ALZpath Inks Licensing Deal With Abbott To Expand Blood-Based Alzheimer's Disease Testing
TipRanks 6d
Abbott and ALZpath announce license agreement

ALZpath, the leader in blood test-based diagnostic solutions for Alzheimer’s disease, announced a licensing agreement with Abbott (ABT) to incorporate ALZpath’s...

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.